TickerFactsScreenerDevelopers

Emmaus Life Sciences, Inc. (EMMA) — Operating Cash Flow

Annual figures by fiscal year, from SEC filings.

2010: -$4.91M2011: -$3.57M2012: -$2.34M2013: -$3.04M2014: -$3.27M2016: -$2.98M2017: -$4.79M2018: -$5.63M2019: -$4.52M2020: -$2.45M2021: -$1.25M2022: -$5.07M2023: -$1.50M2024: -$2.29M2025: -$11.0K-$11.0K
2010Operating Cash Flow (USD)2025
Fiscal YearOperating Cash FlowChange YoY
2025-$11.0K+99.5%
2024-$2.29M-52.1%
2023-$1.50M+70.4%
2022-$5.07M-304.5%
2021-$1.25M+48.8%
2020-$2.45M+45.8%
2019-$4.52M+19.7%
2018-$5.63M-17.6%
2017-$4.79M-60.9%
2016-$2.98M—
2014-$3.27M-7.7%
2013-$3.04M-29.9%
2012-$2.34M+34.5%
2011-$3.57M+27.4%
2010-$4.91M—